JanetLKwiatkowskiMD
Pediatric Hematology & Oncology • Philadelphia, PAProfessor, Pediatrics, Perelman School of Medicine
Dr. Kwiatkowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3500 Civic Center Blvd
Philadelphia, PA 19104- Is this information wrong?
Summary
- Dr. Janet Kwiatkowski is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Children's Hospital of Philadelphia (CHOP). She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 25 years. She is the Director of the Thalassemia Program at CHOP and she also is the Clinical Director of the Sickle Cell and Red Cell Disorders Curative Therapies Center at CHOP. She is experienced in stroke, hemochromatosis, thalassemias, sickle-cell anemia, and iron deficiency anemia. She has more than 100 publications and over 500 citings.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1995 - 1998
Johns Hopkins UniversityResidency, Pediatrics, 1992 - 1995
Columbia University Vagelos College of Physicians and SurgeonsClass of 1992
Certifications & Licensure
PA State Medical License 1995 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study Start of enrollment: 2007 May 01
- Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension Start of enrollment: 2009 Mar 01
- Assessment of Pain in People With Thalassemia Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.Janet L Kwiatkowski, Alexis A Thompson, Fernando Tricta, Noemi Toiber Temin, Anna Rozova, Caroline Fradette, Sherif M Badawy> ;American Journal of Hematology. 2024 Mar 1
- Diagnosis and management of pyruvate kinase deficiency: international expert guidelines.Al-Samkari, H., Shehata, N., Lang-Robertson, K., Bianchi, P., Glenthøj, A., Sheth, S., Neufeld, E., Rees, D., Chonat, S., Kuo, K., Rothman, J., Barcellini, W., van Bee...> ;The Lancet. Haematology. 2024 Mar 1
- Gene addition for beta thalassemia.Janet L Kwiatkowski> ;Annals of the New York Academy of Sciences. 2023 Dec 1
- Join now to see all
Journal Articles
- The Phenotypic Spectrum of Germline YARS2 Variants: From Isolated Sideroblastic Anemia to Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic Anemia 2Matthew M Heeney, Gregory A Hale, David P Steensma, Mark D Fleming, Colin A Sieff, Lee M Hilliard, Sylvia S Bottomley, Janet L Kwiatkowski, Haematologica
Abstracts/Posters
- Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent B...Janet L. Kwiatkowski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyJanet L. Kwiatkowski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyJanet L. Kwiatkowski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- ¤-Thalassemia: Expert Insights on New Therapies for an Old Disease61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Outcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- FDA Approves First Potentially Curative Gene Therapy for Beta ThalassemiaAugust 24th, 2022
Bluebird Bio to Present New Data from Gene and Cell Therapy Programs at 61st American Society of Hematology Annual Meeting and ExpositionNovember 6th, 2019- Physicians’ Education Resource® to Present Six Satellite Symposia at Annual American Society of Hematology Meeting and ExpositionNovember 21st, 2018
- Join now to see all
Grant Support
- Comparative Effectiveness Of Strategies To Improve Iron Chelation In ThalassemiaNational Heart, Lung, And Blood Institute2011
- Thalassemia Clinical Research NetworkNational Heart, Lung, And Blood Institute2006–2009
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Pennsylvania HospitalPhiladelphia, Pennsylvania
Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
